Bertin Technologies
17 News & Press Releases found

Bertin Technologies news

Between collection and analysis, biological samples undergo multiple stress factors that can alter their composition. Lipids are especially vulnerable: in standard tubes, free radicals can react with lipid species and trigger peroxidation, generating artifacts that compromise quantitative accuracy.

The infographic below illustrates this phenomenon. In a regular tube, free radicals present in the blood interact with lipids as soon as the sample is drawn, accelerating oxidative degradat

Jan. 19, 2026

Breast cancer remains one of the most challenging diseases to treat, especially for aggressive forms such as triple-negative breast cancer. Researchers are working relentlessly to better understand tumor metabolism and to find new therapeutic strategies. Two recent studies highlight how critical glutamine metabolism is in breast cancer cells: 

Oct. 8, 2025

We are proud to introduce Myelotracker®, a peptide-based probe. This unique technology specifically targets lactoferrin, a major protein stored in neutrophil granules, making it possible to visualize and study these immune cells with unmatched precision.

Unlike many existing tools, Myelotracker does not activate neutrophils, preserving their natural physiologica

Sep. 23, 2025

Neutrophils are the most abundant white blood cells in the human body and among the very first immune cells to be recruited during inflammation. Yet despite their central role, their study has long been constrained by the lack of reliable tools to monitor their activity in real time. This limitation has made it difficult to fully grasp their contribution to health and disease.

Recent scientific progress is

Sep. 2, 2025

It will be distinguished by its main mirror, 39 metres in diameter and made up of 800 segments, which will be phased and controlled by the Phasing Diagnostic Station (PDS) instrument.

Bertin Winlight will supply all the transport optics for the PDS, which will feed the various optica diagnostics. This involves the custom manufacture of 59 high-precision lenses, once again demonstrating the expertise of our teams in complex optical systems.

The ELT will enable major advances in

May. 26, 2025

Ghrelin, widely recognized as the hunger hormone, is now under the spotlight for its role in mental health. Recent studies suggest that this metabolic signal may influence mood, especially in individuals with major depressive disorder (MDD). This connection between ghrelin and emotional states reve

Apr. 7, 2025

Individual dosimetry monitoring in a hospital environment is a key component of the radiation protection system, designed to measure and control the doses of ionizing radiation received by exposed workers. This monitoring is mandatory under current regulations to limit the impact of radiation on staff health while enabling them to carry out diagnostic and treatment procedures such as X-rays and scans

The Sud-Manche Hospital in France, part of the “Groupe Hospitalier du Mont Sain

Mar. 19, 2025
Challenges in Pharmaceutical Development

Improving the dissolution, solubility, and bioavailability of poorly soluble drugs (BCS Class 2) remains a significant challenge. Amorphous Solid Dispersions (ASDs) are a promising solution, stabilizing drugs in their amorphous form using polymers and low-molecular-weight excipients. However, thermody

Mar. 5, 2025

Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disorder characterized by the progressive formation of fluid-filled cysts in the kidneys, often leading to complicat

Jan. 22, 2025

In the fourth and final application note of our “Mastering Tissue Dissociation” series, we focused on spleen tissue dissociation to isolate single cells.

Using spleen samples from mice housed in standard conditions (UAR BioMedTech Facilities), we achieved a cell viability rate of 87.12%. This method preserves cell integrity, providing high-quality suspensions for spleen research. Bertin Technologies’ Precellys Multi-Tissue Dissociation kit and Precellys

Dec. 5, 2024